Immix Biopharma, Inc. (IMMX)

NASDAQ: IMMX · Real-Time Price · USD

5.83

-0.12 (-2.02%)

At close: Jan 30, 2026, 4:00 PM EST

5.94

+0.11 (1.89%)

After-hours: Jan 30, 2026, 7:30 PM EST

Immix Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 30, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	307	61	137	32	47	-
Market Cap Growth	452.89%	-55.98%	331.07%	-32.18%	-	-
Enterprise Value	292	42	118	15	51	-
Last Close Price	5.83	2.20	6.92	2.29	3.56	-
PB Ratio	23.30	4.57	8.49	2.42	2.61	-
P/TBV Ratio	37.17	4.57	8.38	2.42	2.61	-
Debt / Equity Ratio	0.13	0.08	-	-	0.00	-0.87
Quick Ratio	1.47	2.26	5.02	10.75	87.46	0.10
Current Ratio	1.53	2.33	5.32	11.70	90.01	0.10
Return on Equity (ROE)	-182.55%	-147.33%	-106.22%	-52.84%	-367.80%	-
Return on Assets (ROA)	-66.48%	-66.11%	-57.92%	-31.04%	-9.02%	-38.27%
Return on Capital Employed (ROCE)	-260.60%	-159.00%	-99.60%	-60.30%	-7.50%	9.60%
Earnings Yield	-7.67%	-35.72%	-11.22%	-25.80%	-51.85%	-
FCF Yield	-5.03%	-26.06%	-8.31%	-23.23%	-3.38%	-
Buyback Yield / Dilution	-15.04%	-63.11%	-24.87%	-278.13%	-8.82%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q